<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00893282</url>
  </required_header>
  <id_info>
    <org_study_id>BSTP-001</org_study_id>
    <nct_id>NCT00893282</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of BackStop in Patients Undergoing Intraureteric Stone Lithotripsy</brief_title>
  <official_title>A Randomized, Controlled, Prospective, Single Blind Clinical Evaluation of BackStop in Patients Undergoing Intraureteric Stone Lithotripsy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pluromed, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pluromed, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical study is to evaluate BackStop, a polymer-based device that is
      intended to be used during ureteroscopic lithotripsy to prevent retrograde stone migration.
      It is a water soluble polymer with reverse thermosensitive properties; the polymer exists as
      a liquid at low temperature (below 17 C) and rapidly transitions to a high viscosity gel at
      body temperature (i.e. in the ureter). BackStop is injected above the stones in the ureter
      and is intended to prevent retrograde migration of stones during ureteroscopic lithotripsy.
      Upon completion of the lithotripsy procedure, BackStop dissolves naturally or by irrigation.

      The study hypothesis is that a greater proportion of patients will experience no retropulsion
      of a kidney stone when BackStop is used versus no anti-retropulsion device when undergoing
      intracorporeal lithotripsy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ability of BackStopâ„¢ to minimize migration stone fragments in the proximal ureter will and reported as &quot;yes&quot; or &quot;no&quot;.</measure>
    <time_frame>intra-operative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Extent of residual fragments remaining in ureter at the follow-up visit 2 to 4 weeks post-procedure.</measure>
    <time_frame>one month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In the event that stone fragments migrate retrograde, there may be a need for the physician to employ additional procedures</measure>
    <time_frame>one month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Renal Calculi</condition>
  <condition>Kidney Stones</condition>
  <arm_group>
    <arm_group_label>BackStop</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intracorporeal lithotripsy with the use of an anti-retropulsion device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No anti-retropulsion device will be used during lithotripsy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BackStop</intervention_name>
    <description>BackStop in a gel plug that potentially prevents retropulsion during intracorporeal lithotripsy.</description>
    <arm_group_label>BackStop</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intracorporeal lithotripsy without the use of an anti-retropulsion device</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with a solitary, radio-opaque ureteral stone in the proximal ureter.

          -  Clinical indication for treatment by ureteroscopic lithotripsy.

          -  Minimum 18 years old (or any institutional age limits for participation in clinical
             study).

          -  Patients must be willing and able to participate in any follow-up visits, as required.

          -  Patients must provide informed consent.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>McGill University Health Center</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2009</study_first_submitted>
  <study_first_submitted_qc>May 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2009</study_first_posted>
  <last_update_submitted>May 4, 2009</last_update_submitted>
  <last_update_submitted_qc>May 4, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2009</last_update_posted>
  <responsible_party>
    <name_title>James Wilkie, Vice President, Operations</name_title>
    <organization>Pluromed, Inc.</organization>
  </responsible_party>
  <keyword>renal</keyword>
  <keyword>calculi</keyword>
  <keyword>kidney</keyword>
  <keyword>stones</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calculi</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

